Omisirge Kit
Product Images NDC 73441-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Omisirge (NDC 73441-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gamida Cell Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Omisirge 01)

Figure 1 (Omisirge 01)
An instructional diagram showing patient-specific identifiers on a metal cassette label and a cryopreserved bag label for OMISIRGE cellular therapy kit. It details visible patient information fields including Patient Name, Date of Birth, Gamida Cell Patient ID, and Hospital Patient ID on both labels, demonstrating label placement and identification.*
FDA Label Image

Figure 2 (Omisirge 02)

Figure 2 (Omisirge 02)
Illustration of a cellular therapy kit bag for OMISIRGE (omidubicel-onlv) showing two attached fluid bags and a label with patient-specific identifiers including Patient Name, Date of Birth, Gamida Cell Patient ID, and Hospital Patient ID.*
FDA Label Image

Principal Display Panel (20 mL and 10 mL Bag Label)

Principal Display Panel (20 mL and 10 mL Bag Label)
Label for OMISIRGE (omidubicel-onlv) cellular therapy kit by Gamida Cell Inc., Boston, MA. The label includes patient and batch IDs, shipment details to a transplant center, manufacturer contact, and storage instructions specifying shipping and storing in vapor phase liquid nitrogen at ≤ -150°C with a warning not to X-ray. The label also distinguishes between cultured and non-cultured fractions and indicates this is container 1 of 2.*
FDA Label Image

Principal Display Panel (80 mL and 40 mL Bag Label)

Principal Display Panel (80 mL and 40 mL Bag Label)
Label for OMISIRGE (omidubicel-onlv) cellular therapy kit, container 2 of 2. The label includes barcodes with NDCs 73441-300-01 and 73441-400-01, patient and batch ID placeholders, and expiry date format. It differentiates infusion solutions for cultured and non-cultured fractions. The product is made in Israel and distributed by Gamida Cell, Inc., Boston, MA. Storage instructions note to keep at 2–8°C and not to X-ray. The label contains spaces for transplant center shipping information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.